---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-23-000035"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2023-06-08T23:59:59+00:00"
generated_at: "2026-06-14T05:22:55.291573+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health raises FY2023 EPS outlook, provides FY2024 guide of $6.45-$6.70, $3.5B buyback

## Summary
- Narrows FY2023 non-GAAP EPS guidance to $5.65-$5.80 (mid-point 13% growth); preliminary FY2024 guidance $6.45-$6.70 (15% growth).
- Long-term target: 12%-14% non-GAAP EPS CAGR over FY2024-2026; Pharmaceutical segment profit growth 4%-6%.
- Board approves new $3.5B share repurchase authorization through 2027; plans at least $2B in buybacks over next three years.
- Launches Navista Network for community oncology; retains and invests in Nuclear & Precision Health Solutions.
- Medical Improvement Plan targets $650M+ segment profit by FY2026; $400M expected in FY2024.

## SEC filing metadata
- accession: 0000721371-23-000035
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2023-06-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137123000035/0000721371-23-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137123000035/cah-20230608.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-23-000035
- JSON: https://secwatch.observer/filing/0000721371-23-000035.json
- Plain text: https://secwatch.observer/filing/0000721371-23-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.